Noxopharm Ltd. (AU:NOX) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Noxopharm Limited, an Australian biotech firm, has announced its upcoming 2024 AGM to be held on 19 November as a physical event, where important resolutions will be voted on including director re-elections and approval of future securities issues. The company, known for developing cancer and inflammation treatments and enhancing mRNA vaccines, encourages shareholders to participate in the meeting due to the significance of the resolutions on their shareholding. All relevant AGM documents are available for review by shareholders online and via the company secretary.
For further insights into AU:NOX stock, check out TipRanks’ Stock Analysis page.